These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16207271)

  • 1. Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital.
    Colls BM
    Intern Med J; 2005 Oct; 35(10):640. PubMed ID: 16207271
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous inappropriate use of serum tumour markers.
    Tran HA
    Intern Med J; 2005 Oct; 35(10):640-1; author reply 641. PubMed ID: 16207270
    [No Abstract]   [Full Text] [Related]  

  • 3. An audit of tumour marker requests in Northern Ireland.
    McDonnell M;
    Ann Clin Biochem; 2004 Sep; 41(Pt 5):378-84. PubMed ID: 15333189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of tumour marker utilization in Greece.
    Ntaios G; Hatzitolios A; Chatzinikolaou A; Karalazou P; Savopoulos C; Karamouzis M; Pidonia I
    Eur J Intern Med; 2009 May; 20(3):e66-9. PubMed ID: 19393482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour markers: from laboratory to clinical use.
    Torre GC; Lucchese V; Rembado R; Barbetti V
    Anticancer Res; 1996; 16(4B):2215-9. PubMed ID: 8694546
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum tumour markers: how to order and interpret them.
    Sturgeon CM; Lai LC; Duffy MJ
    BMJ; 2009 Sep; 339():b3527. PubMed ID: 19773328
    [No Abstract]   [Full Text] [Related]  

  • 7. [Good clinical use of serum tumor markers].
    Boussen H; el May M; Jerbi G; Rahal K; Benna F; Mtimet S; Ben Ayed F
    Tunis Med; 1998 Feb; 76(2):1020-6. PubMed ID: 9844536
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extracellular DNA in plasma--a potential diagnostic marker in oncology].
    Gaziev AI; Shaĭhaev GO; Korenev SV
    Vopr Onkol; 2008; 54(5):545-54. PubMed ID: 19069466
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P; Meleady P; Dowling P; Clynes M
    Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer.
    Cordero OJ; De Chiara L; Lemos-González Y; Páez de la Cadena M; Rodríguez-Berrocal FJ
    Anticancer Res; 2008; 28(4C):2333-41. PubMed ID: 18751415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers].
    Sirotteau JC
    Soins; 1990 Feb; (533):33-5. PubMed ID: 2321057
    [No Abstract]   [Full Text] [Related]  

  • 12. Introduction to tumor markers from A to Z.
    Plaut D
    MLO Med Lab Obs; 2004 Aug; 36(8):22, 26. PubMed ID: 15366364
    [No Abstract]   [Full Text] [Related]  

  • 13. High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy.
    Paneesha S; Cheyne E; French K; Delgado J; Borg A; Rose P
    Haematologica; 2005 Dec; 90(12 Suppl):ELT08. PubMed ID: 16464765
    [No Abstract]   [Full Text] [Related]  

  • 14. Community hospital versus tertiary hospital comparison in the treatment and outcome of patients with acute coronary syndrome: a New Zealand experience.
    Tang EW; Wong CK; Herbison P
    N Z Med J; 2006 Jul; 119(1238):U2078. PubMed ID: 16868575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between various tumor marker.
    Pastore M; Sbaffi A; Francioni S; Castellaro E
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):239-50. PubMed ID: 2092126
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
    Diamandis EP
    Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple biomarkers in molecular oncology.
    Johann DJ; Veenstra TD
    Expert Rev Mol Diagn; 2007 May; 7(3):223-5. PubMed ID: 17489728
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.
    Brenner DE; Normolle DP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1918-20. PubMed ID: 17932336
    [No Abstract]   [Full Text] [Related]  

  • 19. Using medical audit results to plan continuing medical education in community hospitals.
    Osborne CE
    Annu Conf Res Med Educ; 1980; (19):129-34. PubMed ID: 7458190
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.